Investors got big returns on the initial sale and could see millions more over the coming years, as Harpoon's device continues on the path to U.S. regulatory approval.
Investors got big returns on the initial sale and could see millions more over the coming years, as Harpoon's device continues on the path to U.S. regulatory approval.